MitraClip Implantation Guided by Volumetric Intracardiac Echocardiography: Technique and Feasibility in Patients Intolerant to Transesophageal Echocardiography.
Intracardiac echocardiography
MitraClip
Journal
Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
12
01
2021
accepted:
14
01
2021
pubmed:
6
2
2021
medline:
25
2
2023
entrez:
5
2
2021
Statut:
ppublish
Résumé
Transesophageal echo (TEE) guidance is essential for successful MitraClip implantation. In patients intolerant to TEE, options are limited. Three patients, with contraindications to TEE, underwent MitraClip implantation using volumetric intracardiac echo (vICE). All patients had severe symptomatic degenerative mitral regurgitation (MR) and had successful implantation of at least one clip with reduction of MR to ≤2+ maintained at 30d follow-up. All patients had improvement in functional status without any adverse clinical, clip, or vICE related events. We discuss in detail the technical considerations and limitations to performing the MitraClip procedure with vICE guidance.
Identifiants
pubmed: 33541810
pii: S1553-8389(21)00048-8
doi: 10.1016/j.carrev.2021.01.019
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
85-88Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Gagan D. Singh, Jason H Rogers and Thomas W.R. Smith are consultants for Abbott Vascular. Jason H Rogers and Thomas W.R. Smith are consultants for Boston Scientific and Gore Medical. Gagan D. Singh is a consultant for Siemens Healthcare. Edris Aman is a consultant for SilaraMedTech and MVRx. The rest of the authors have no relevant disclosures to declare.